Jemster Healthcare Private Limited logo

Jemster Healthcare Private Limited

Produces and distributes DCGI-approved pharmaceutical formulations, including analgesics, antibiotics, and supplements.
2018 | Chandigarh, Chandigarh (India) | Active

Last Updated:

July 06, 2024
HomeCompanyJemster Healthcare Private Limited

Who are the key members and board of directors at Jemster Healthcare?

Board Members(2)

NameDesignationAppointment DateStatus
Jeet Jain In Director 12-Dec-2018Current
Yatin Jain In Director 03-Jul-2018Current

Financial Performance of Jemster Healthcare.

Jemster Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 139.72% increase. The company also saw a substantial improvement in profitability, with a 108.52% increase in profit. The company's net worth Soared by an impressive increase of 502.6%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
139.72%
Revenue from Operations
139.72%
Total Assets
17.31%
Profit or Loss
108.52%
Net Worth
502.60%
EBITDA
-21.97%

Related Corporates (Common Directorship)

Charges (Loans)

Satisfied Charges

₹1.00 M

LenderAmountStatus

State Bank Of India

Creation Date: 19 Jan 2021
₹1.00 MSatisfied

How Many Employees Work at Jemster Healthcare?

Unlock and access historical data on people associated with Jemster Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Jemster Healthcare

Recent activity within the organization

  • Annual General Meeting

    Jemster Healthcare Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.

    29 Sep 2023

  • Balance Sheet

    Jemster Healthcare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.

    31 Mar 2023

  • Charges

    A charge registered on 19 Jan 2021 via Charge ID 100413458 with State Bank Of India was fully satisfied on 02 Jun 2021.

    02 Jun 2021

  • Charges

    A charge with State Bank Of India amounted to Rs. 1.00 M with Charge ID 100413458 was registered on 19 Jan 2021.

    19 Jan 2021

  • Director Appointment

    Jeet Kumar Jain was appointed as a Director was appointed as a Director on 12 Dec 2018 & has been associated with this company since 6 years 12 days .

    12 Dec 2018

  • Director Appointment

    Yatin Jain was appointed as a Director was appointed as a Director on 03 Jul 2018 & has been associated with this company since 6 years 5 months .

    03 Jul 2018

Frequently asked questions

  • Jemster Healthcare Private Limited was incorporated on 03 Jul 2018.

  • The authorized share capital of Jemster Healthcare Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.20 M.

  • Currently 2 directors are associated with Jemster Healthcare Private Limited.

    • Jeet Kumar Jain
    • Yatin Jain
  • As per Ministry of Corporate Affairs (Mca), the registered address of Jemster Healthcare Private Limited is Building No:87-88 Ground Floor, Near Gurudwara Village Raipur Kalan, Chandigarh, India, 160102.

  • The corporate identification number (CIN) of Jemster Healthcare Private Limited is U74999CH2018PTC042056 and the company number is 042056 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Jemster Healthcare Private Limited is https://www.jemsterhealthcare.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Jemster Healthcare Private Limited has risen by 139.72%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Jemster Healthcare Private Limited has experienced an upsurge of 502.60%.

  • The most recent Balance Sheet for Jemster Healthcare Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development